14-95103856-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000343455.8(DICER1):c.3540C>A(p.Tyr1180Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y1180Y) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000343455.8 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DICER1 | NM_177438.3 | c.3540C>A | p.Tyr1180Ter | stop_gained | 21/27 | ENST00000343455.8 | NP_803187.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DICER1 | ENST00000343455.8 | c.3540C>A | p.Tyr1180Ter | stop_gained | 21/27 | 1 | NM_177438.3 | ENSP00000343745 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727246
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
DICER1-related tumor predisposition Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | International Pleuropulmonary Blastoma Registry, Children's Hospitals and Clinics of Minnesota | Nov 10, 2014 | - - |
Pathogenic, criteria provided, single submitter | curation | Foulkes Cancer Genetics LDI, Lady Davis Institute for Medical Research | Jul 01, 2019 | ACMG criteria met: PVS1, PM2, PP4 - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 254323). This variant is also known as c.3722C>A (Y1170*). This premature translational stop signal has been observed in individual(s) with clinical features of DICER1 syndrome (PMID: 19556464, 30178239). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr1180*) in the DICER1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DICER1 are known to be pathogenic (PMID: 19556464, 21266384). - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jan 16, 2023 | This nonsense variant causes the premature termination of DICER1 protein synthesis. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). In the published literature, the variant has been reported in multiple individuals with pleuropulmonary blastoma (PMIDs: 19556464 (2009) and 26925222 (2015)), in an individual with cystic nephroma (PMID: 30178239 (2018)), and in an individual with an ovarian Sertoli-Leydig cell tumor, well-differentiated fetal adenocarcinoma of the lung, and familial multinodular goiter (PMIDs: 25451712 (2014), 26886166 (2016)). Based on the available information, this variant is classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 12, 2018 | The Y1180X variant in the DICER1 gene has been reported previously in a family with pleuropulmonary blastoma, and in an individual with ovarian Sertoli-Leydig tumor, fetal adenocarcinoma of the lung, and familial multinodular goiter (Hill et al., 2009; Brenneman et al., 2015; Wu et al., 2014). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The Y1180X variant is not observed in large population cohorts (Lek et al., 2016). We interpret Y1180X as a pathogenic variant. - |
Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 15, 2023 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2023 | The p.Y1180* pathogenic mutation (also known as c.3540C>A), located in coding exon 20 of the DICER1 gene, results from a C to A substitution at nucleotide position 3540. This mutation has been reported in multiple individuals with pleuropulmonary blastoma (PPB) (Hill DA et al. Science. 2009;325(5943):965; Brenneman M et al. F1000Res, 2015 Jul;4:214). This mutation was also detected a female with a personal history of a multinodular goiter at age 14, as well as an ovarian Sertoli-Leydig cell tumor and a well-differentiated fetal adenocarcinoma of the lung (WDFA) at age 16 (Wu Y et al. Eur J Med Genet; 57(11-12):621-5; de Kock L et al. J Thorac Oncol, 2016 Mar;11:e31-3). Of note, this mutation is also designated as Y1170X in published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at